• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法莫替丁在胃食管反流管理中的应用

Famotidine in the management of gastro-oesophageal reflux.

作者信息

Okoth F A, Lule G N, Ogutu E O, Pilczer S, Dubois C

机构信息

Kenya Medical Research Institute, (KEMRI), Nairobi.

出版信息

East Afr Med J. 1994 Jan;71(1):44-8.

PMID:8055765
Abstract

Famotidine has been used for the treatment of peptic ulcers and Zollinger Ellison syndrome and is also useful in reflux and erosive oesophagitis. To evaluate the effects of Famotidine 20 mg given twice daily in the symptomatic relief of gastro-oesophageal reflux disease with normal oesophagus or mild endoscopic oesophagitis, patients were followed over a period of six weeks. 70% of the patients had complete day-time heartburn relief during the study and 75% had complete night-time heartburn relief during the study. Famotidine was found to be safe and there were no serious clinical or laboratory adverse experiences.

摘要

法莫替丁已被用于治疗消化性溃疡和卓艾综合征,对反流性食管炎和糜烂性食管炎也有效。为评估每日两次服用20毫克法莫替丁对食管正常或轻度内镜下食管炎的胃食管反流病症状缓解的效果,对患者进行了为期六周的随访。70%的患者在研究期间白天烧心症状完全缓解,75%的患者在研究期间夜间烧心症状完全缓解。结果发现法莫替丁是安全的,没有严重的临床或实验室不良事件。

相似文献

1
Famotidine in the management of gastro-oesophageal reflux.法莫替丁在胃食管反流管理中的应用
East Afr Med J. 1994 Jan;71(1):44-8.
2
[Symptomatic therapy with famotidine in non-erosive gastro-esophageal reflux. Results of an open multicenter study].[法莫替丁对症治疗非糜烂性胃食管反流病。一项开放性多中心研究的结果]
Arzneimittelforschung. 1995 Apr;45(4):499-504.
3
Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.法莫替丁和奥美拉唑治疗非糜烂性胃食管反流病症状的疗效:胃食管反流病的随机对照研究
Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:2-9. doi: 10.1111/j.1365-2036.2005.02467.x.
4
Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.法莫替丁与奥美拉唑对比:一项前瞻性随机多中心试验,以确定在非糜烂性胃食管反流病中的疗效。
Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:10-8. doi: 10.1111/j.1365-2036.2005.02468.x.
5
Review article: Gastro-oesophageal reflux disease--application of the concept of complete remission.综述文章:胃食管反流病——完全缓解概念的应用
Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:13-6. doi: 10.1111/j.1365-2036.2007.03493.x.
6
Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?各种形式的胃食管反流病的病理生理特征。是谱系疾病还是不同的表型表现?
Dig Liver Dis. 2006 Sep;38(9):643-8. doi: 10.1016/j.dld.2006.02.020. Epub 2006 Apr 14.
7
The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.不同胃食管反流病组之间食管酸暴露重叠的程度。
Aliment Pharmacol Ther. 2006 Jan 15;23(2):321-9. doi: 10.1111/j.1365-2036.2006.02747.x.
8
Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis.诊断后3至4.5年,通过重复食管pH监测和内镜检查确定的胃食管反流病的疾病进展。
Eur J Gastroenterol Hepatol. 1997 Dec;9(12):1161-7.
9
Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.无食管炎的胃食管反流病(NERD)的自然史——10年后的重新评估
Dig Liver Dis. 2004 Feb;36(2):111-5. doi: 10.1016/j.dld.2003.10.012.
10
Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.基层医疗中的胃食管反流病:一项关于奥美拉唑不同治疗策略的国际研究。国际胃食管反流病研究组
Eur J Gastroenterol Hepatol. 1998 Feb;10(2):119-24.